| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 559,630 | 539,103 | 617,538 | 636,126 | | Cost of Revenue | 337,430 | 324,465 | 370,799 | 372,351 | | | Gross Profit | 222,200 | 214,638 | 246,739 | 263,775 | | | Operating Expenses | | Research Development | 50,189 | 52,344 | 52,129 | 56,166 | | Selling General and Administrative | 89,424 | 94,564 | 92,466 | 104,662 | | Non Recurring |
-
| 12,245 |
-
| (255) | | Others | 1,538 | 1,538 | 1,537 | 1,540 | | | | Total Operating Expenses |
-
| 160,691 |
-
| 162,113 | | | | Operating Income or Loss | 81,049 | 53,947 | 100,607 | 101,662 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,162 | 3,989 | (3,004) | 4,119 | | Earnings Before Interest And Taxes | 82,211 | 57,936 | 97,603 | 105,781 | | Interest Expense | 19,781 | 19,207 | 18,037 | 18,545 | | Income Before Tax | 62,430 | 38,729 | 79,566 | 87,236 | | Income Tax Expense | 15,233 | (10,240) | 21,882 | 20,209 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 47,197 | 48,969 | 57,684 | 67,027 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 47,197 | 48,969 | 57,684 | 67,027 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $47,197 | $48,969 | $57,684 | $67,027 |
|
0.45% Nasdaq 
0.20%
Income Statement
